Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec.

Bechtold, R E; Chen, M Y M; Stanton, C A; Savage, P D; Levine, E A

Bechtold, R E; Chen, M Y M; Stanton, C A; Savage, P D; Levine, E A.

Affiliation

Bechtold RE; Department of Radiology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157-1088, USA.

Abdom Imaging ; 28(6): 808-14, 2003.

Article in En | MEDLINE | ID: mdl-14753595

Subject(s)

Antineoplastic Agents/therapeutic use; Gastrointestinal Neoplasms/pathology; Liver Neoplasms/drug therapy; Liver Neoplasms/secondary; Peritoneal Neoplasms/drug therapy; Peritoneal Neoplasms/secondary; Piperazines/therapeutic use; Protein-Tyrosine Kinases/antagonists & inhibitors; Pyrimidines/therapeutic use; Adult; Aged; Benzamides; Female; Follow-Up Studies; Humans; Imatinib Mesylate; Male; Middle Aged; Retrospective Studies; Stromal Cells; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Neoplasms / Piperazines / Pyrimidines / Protein-Tyrosine Kinases / Gastrointestinal Neoplasms / Liver Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Abdom Imaging Journal subject: DIAGNOSTICO POR IMAGEM / GASTROENTEROLOGIA Year: 2003 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links